← All presentations

7 slides

Risk of stockouts: what the tax reform alarm reveals about the pharma supply chain

Tax reform discussions and stockout risks expose the industry's lack of prior visibility into actual point-of-sale inventory.

Risk of stockouts: what the tax reform alarm reveals about the pharma supply chain

Tax reform discussions and stockout risks expose the industry's lack of prior visibility into actual point-of-sale inventory.

Part 1

When major discussions about structural or tax reforms return to the center of regulatory debate, the pharmaceutical sector reacts immediately with the legitimate fear of stockouts and unsustainable pressure on logistical margins.

Part 2

There is an undeniable truth to this concern: macroeconomic shocks and tax changes alter cost dynamics and demand complex adjustments in the supply chain. However, focusing all attention solely on the external factor conceals a prior and much more urgent operational fragility.

Part 3

To understand the problem, it is necessary to separate two concepts that are frequently confused: the macroeconomic cost shock and operational availability visibility. The first concerns fiscal rules, input inflation, and freight conditions.

Part 4

When a stockout alarm gains traction in the market, the practical effect is usually a delayed reaction. Without consolidated and updated data per point of sale, executive decisions end up being made based on delayed reports or generic field perceptions.

Part 5

It is clear that data intelligence does not replace tax reforms nor control government decisions. The fiscal impact will continue to require financial planning and rigorous commercial negotiation. However, having a structured reading of availability drastically reduces the cost of reacting in the dark.

Part 6

Continuous visibility does not eliminate macroeconomic risks, but it ensures that the operation does not stumble over its own data when making critical decisions. The question that remains for your company's planning is: how does your operation separate today the stockout risk generated by external shocks from the lack of visibility at the point of sale?

Read the full article →

Turn data into decisions

Dinn shows where pharmacies lack the product, what changed and where to act first, with source and confidence.

Other presentations